naturalX Health Ventures
VC Fund
Berlin, Germany
NaturalX Health Ventures is an investment company of Schwabe Group that focuses its investment in consumer health companies. The company strives to merge the growth opportunities of youthful and innovative businesses with the financial stability and diverse expertise provided by our parent company.NaturalX Health Ventures invests across variousstages from seed to late, with a primary emphasis on series A and series B investments, indicating a robust indication of product-market fit. The firm's focus centers on innovations at the crossroads of natural and digital health.
- Total investments:
- 6
- Last investment:
- Lead investor:
- 17%
Last updated:
For AI agents: llms.txt
Industries naturalX Health Ventures invests in
Stages naturalX Health Ventures invests in
Countries naturalX Health Ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
4 more contacts available
Round size
- Series A
- $5.9M–$28M
Investment Focus
Industry
- Health Care 6 (100%)
- Wearables 2 (33%)
- Medical Device 2 (33%)
- Health Diagnostics 2 (33%)
- Medical 1 (17%)
Stage
- Series A 4 (67%)
- Series B 1 (17%)
- Convertible Note 1 (17%)
Country
- Switzerland 3 (50%)
- Poland 1 (17%)
- Sweden 1 (17%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Marvin Amberg
Managing Director
|
Managing Director | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Ilant Health
|
Ilant Health provides treatment for obesity and weight management. | $15M / Series A / Apr 09, 2026 | |
Jutro Medical
|
Jutro Medical offers a combination of online and offline primary care — pairing mobile first telemedicine with physical clinic | $28.2M / Series A / Dec 16, 2025 | |
Hilo
|
Founded in Switzerland in May 2018 out of a passion to turn insights into action in the fight against hypertension, Aktiia’s groundbreaking medical technology provides people and their physicians comprehensive insights into blood pressure patterns that will inform the diagnosis and management of hypertension. Now available in the United Kingdom,Aktiia has received its CE Mark as a Class IIa medical device - signifying that the device has been assessed to meet high safety, health and environmental protection requirements in Europe. To learn more, visit Aktiia.com. | $42M / Series B / May 01, 2025 | |
Kyan Health
|
Kyan Health is the first Swiss digital health company to provide end-to-end, fully personalized, evidence-based mental wellbeing and health solutions for employees and their families. The company's mission is to create a frictionless experience when accessing and engaging with mental health and wellbeing support services at work – fromemployee engagement and awareness creation over self-improvement and self-care to coaching and counseling. | $12.7M / Series A / Nov 26, 2024 | |
Flow Neuroscience
|
Flow Neuroscience is a healthcare company that develops depression treatment devices that combines an easy-to-use brain stimulation headset with a personalized mobile app to target both the physical and behavioral elements of Major Depressive Disorder (MDD). The company's wearable stimulates a patient's left frontal lobe, the area of thebrain that has often lowered activity in people suffering from depression.Flow Neuroscience combines their wearable with a mobile app that nudges users to behaviors that will help lessen the effects of their depression, including exercise and regular sleeping patterns.The company's hope is to make available for the public a treatment that's currently only used in clinics specialized in brain stimulation. It also wants to make the treatment affordable enough to seriously challenge a dominant pharmaceuticals industry. | Convertible Note / Jul 18, 2024 | |
mybacs
|
mybacs is a DTC, research-driven, Biotechnology company specialized in the human microbiome. Our goal is to revolutionize the market around intestinal healthcare and thus make a decisive contribution to the daily well-being of our customers. Our team of pharmaceutical scientists and physicians is focused on the development of innovative andhighly-dosed synbiotic supplements. These are aligned by our singular formulations from specifically selected probiotic cultures, prebiotics as well as minerals and vitamins tailored to the individual needs of our customers. | $5.9M / Series A / Oct 19, 2023 |
Co-Investors
Joyance Partners
2 deals together
SOSV
2 deals together
AlphaLab
1 deal together
Aternus
1 deal together
Celtic
1 deal together
Cornucopian Capital
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does naturalX Health Ventures invest in?
naturalX Health Ventures invests primarily in Health Care, Wearables and Medical Device startups, most often at Series A and Series B stage. Most of the 6 investments tracked by Shizune back companies in Switzerland. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is naturalX Health Ventures's check size?
naturalX Health Ventures typically joins rounds of $5.9M–$28M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds naturalX Health Ventures participates in.
How do I contact naturalX Health Ventures?
Public channels for naturalX Health Ventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at naturalX Health Ventures?
The team at naturalX Health Ventures includes Marvin Amberg (Managing Director). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
